The Pharmacy Times® Oncology Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to oncology pharmacists.
March 18th 2024
The authors note that understanding the DNA methylation profile in leukemia can help predict whether or not a patient will respond to treatment.
Novel Combination Therapies in Relapsed/ Refractory Classical Hodgkin Lymphoma
Data shed light on brentuximab vedotin plus nivolumab, bendamustine, or gemcitabine.
Read More
FDA Accepts Priority Review for Linvoseltamab to Treat Adult Patients With R/R MM
February 22nd 2024Currently, the safety and efficacy of linvoseltamab in adult patients with relapsed or refractory multiple myeloma is being compared to elotuzumab, pomalidomide, and dexamethasone in a phase 3 clinical trial.
Read More
Advancing Pharmacists’ Role in Personalized Treatment for Breast, Prostate, and Lung Cancer
Precision oncology represents an evolution in therapeutic practice.
Read More
The Blood Detective: Tackling Medication-Induced Hematological Disorders
These disorders can be fatal, making pharmacists’ role in detection crucial.
Read More